Sarda Proteins Ltd (BOM:519242)

Sarda Proteins Statistics

Total Valuation

Sarda Proteins has a market cap or net worth of INR 121.52 million. The enterprise value is 121.75 million.

Market Cap	121.52M
Enterprise Value	121.75M

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Sarda Proteins has 1.73 million shares outstanding. The number of shares has increased by 2.97% in one year.

Current Share Class	1.73M
Shares Outstanding	1.73M
Shares Change (YoY)	+2.97%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	34.28%
Owned by Institutions (%)	3.46%
Float	1.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.31
PB Ratio	5.31
P/TBV Ratio	5.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-112.01
EV / Sales	0.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.07.

Current Ratio	1.03
Quick Ratio	0.15
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -4.64% and return on invested capital (ROIC) is -8.34%.

Return on Equity (ROE)	-4.64%
Return on Assets (ROA)	-0.28%
Return on Invested Capital (ROIC)	-8.34%
Return on Capital Employed (ROCE)	-8.20%
Weighted Average Cost of Capital (WACC)	-12.44%
Revenue Per Employee	196.55M
Profits Per Employee	-543,500
Employee Count	2
Asset Turnover	0.88
Inventory Turnover	n/a

Taxes

In the past 12 months, Sarda Proteins has paid 151,000 in taxes.

Income Tax	151,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.80% in the last 52 weeks. The beta is -3.06, so Sarda Proteins's price volatility has been lower than the market average.

Beta (5Y)	-3.06
52-Week Price Change	-37.80%
50-Day Moving Average	100.09
200-Day Moving Average	75.12
Relative Strength Index (RSI)	36.48
Average Volume (20 Days)	2,724

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sarda Proteins had revenue of INR 393.10 million and -1.09 million in losses. Loss per share was -0.64.

Revenue	393.10M
Gross Profit	2.42M
Operating Income	-2.01M
Pretax Income	-936,000
Net Income	-1.09M
EBITDA	n/a
EBIT	-2.01M
Loss Per Share	-0.64

Balance Sheet

The company has 1.32 million in cash and 1.55 million in debt, with a net cash position of -229,000 or -0.13 per share.

Cash & Cash Equivalents	1.32M
Total Debt	1.55M
Net Cash	-229,000
Net Cash Per Share	-0.13
Equity (Book Value)	22.89M
Book Value Per Share	13.24
Working Capital	23.14M

Cash Flow

Operating Cash Flow	-828.18M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 0.62%, with operating and profit margins of -0.51% and -0.28%.

Gross Margin	0.62%
Operating Margin	-0.51%
Pretax Margin	-0.24%
Profit Margin	-0.28%
EBITDA Margin	n/a
EBIT Margin	-0.51%
FCF Margin	n/a

Dividends & Yields

Sarda Proteins does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.97%
Shareholder Yield	-2.97%
Earnings Yield	-0.89%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sarda Proteins has an Altman Z-Score of 0.62 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.62
Piotroski F-Score	1